PCSK9-IN-27
PCSK9-IN-27 (Compound 108) is a PCSK9 inhibitor (IC50: 3.4 nM) . PCSK9-IN-27 reduces LDLR degradation and increases LDL-C uptake[1].
Product Specifications
UNSPSC
12352005
Target
PCSK9
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/pcsk9-in-27.html
Solubility
10 mM in DMSO
Smiles
O=C1N(C=CC=C1Cl)C2=CN=C(N[C@@H]3C[C@@H](NC4=CN=C(C5CC5)C=N4)CC3)C=C2
Molecular Formula
C22H23ClN6O
Molecular Weight
422.91
References & Citations
[1]Gavin Donal O’MAHONY, et al. Pcsk9 inhibitors and methods of use thereof. Patent. WO2024062089A1
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
